- Home
- PYPD vs PT Comparison
PYPD vs PT Comparison
Compare PYPD & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- PT
- Stock Information
- Founded
- PYPD 2008
- PT 2012
- Country
- PYPD Israel
- PT China
- Employees
- PYPD N/A
- PT N/A
- Industry
- PYPD Medical/Dental Instruments
- PT Computer Software: Programming Data Processing
- Sector
- PYPD Health Care
- PT Technology
- Exchange
- PYPD Nasdaq
- PT Nasdaq
- Market Cap
- PYPD 16.3M
- PT 14.8M
- IPO Year
- PYPD 2020
- PT 2018
- Fundamental
- Price
- PYPD $3.47
- PT $0.98
- Analyst Decision
- PYPD Buy
- PT
- Analyst Count
- PYPD 2
- PT 0
- Target Price
- PYPD $12.00
- PT N/A
- AVG Volume (30 Days)
- PYPD 4.8K
- PT 39.9K
- Earning Date
- PYPD 11-06-2024
- PT 04-30-2024
- Dividend Yield
- PYPD N/A
- PT N/A
- EPS Growth
- PYPD N/A
- PT N/A
- EPS
- PYPD N/A
- PT N/A
- Revenue
- PYPD N/A
- PT $7,434,458.00
- Revenue This Year
- PYPD N/A
- PT N/A
- Revenue Next Year
- PYPD N/A
- PT N/A
- P/E Ratio
- PYPD N/A
- PT N/A
- Revenue Growth
- PYPD N/A
- PT N/A
- 52 Week Low
- PYPD $2.95
- PT $0.71
- 52 Week High
- PYPD $9.20
- PT $1.38
- Technical
- Relative Strength Index (RSI)
- PYPD 46.98
- PT 48.96
- Support Level
- PYPD $3.37
- PT $0.88
- Resistance Level
- PYPD $3.65
- PT $1.01
- Average True Range (ATR)
- PYPD 0.17
- PT 0.11
- MACD
- PYPD -0.00
- PT -0.01
- Stochastic Oscillator
- PYPD 36.36
- PT 61.11
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.